Needle-Free Drug Injection Systems and Safety Syringes: Market Research Report

June 2012 | 504 pages | ID: N1602849B1AEN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2010 through 2018.

A six-year historic analysis is also provided for these markets.

The report profiles 93 companies including many key and niche players such as First Principals, Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, Bioject Medical Technologies, Inc., Covidien Plc, Crossject Ltd., D'Antonio Consultants International, Inc., Glide Pharmaceutical Technologies Ltd., Incline Therapeutics, Inc., INJEX Pharma GmbH, Medical International Technologies (Mit Canada), Inc., National Medical Products, Inc., PenJet Corporation, PowderJect Pharmaceuticals Plc, Retractable Technologies, Inc., Safety Syringes, Inc., Smiths Group, Smiths Medical, Terumo Corporation, Unilife Medical Solutions Ltd., Valeritas, Ypsomed Holding AG, and Zogenix, Inc.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based upon search engine sources in the public domain.

Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Safety Syringes
Needle-Free Injections

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

A Prelude
Market Overview
Current and Future Analysis
Needlestick Injuries – A Menace in Healthcare Environment
Evolving Drug Delivery Systems
Factors Determining User Choice in Safety Syringes
Factors Enabling Espousal of Safety and Pre-filled Injections
Major Advantages of Needle-Free Injection Systems
Legislations – The Base for Technology Improvements and Demand
Ongoing Research to Further Advance Delivery Systems, Fuel Market Growth
Future Market to Offer Multiple Drug Delivery Alternatives
Needle-Free Injection Systems Market
Demand for Needle-Free Systems Gathers Pace
Trends toward Needle-Free Injections
Extending Patent Life through Differentiation from Competitive Generics
Safety and Efficacy – Amongst the Prime Motivating Factors
Patient Involvement
Needle-Free Future Unlikely
Regulations – A Shot on the Arm for Needle-free Market
Safety Syringes Market
Demand for Pre-filled Safety Syringes North-Bound
Pre-filled Syringes – Benefiting All Stakeholders
Markets Crave for Further Advancements in Safety Syringes
Insulin Delivery – A Burgeoning Market for Novel Delivery Systems
Competitive Landscape

Table 1. Leading Suppliers of Safety Syringes Worldwide (2011E): Percentage Breakdown of Sales for Becton, Dickinson and Company, Covidien, Terumo, Retractable and Others (includes corresponding Graph/Chart)

Other Key Statistics

Table 2. Leading Pharmaceutical Companies in the Pre-Filled Vaccine Syringes Market (2011): Percentage Breakdown of Revenues for GSK, Sanofi, Novartis and Others (includes corresponding Graph/Chart)

Table 3. Leading Pharmaceutical Companies in the Pre-Filled Hematology Syringes Market (2011): Percentage Breakdown of Revenues for Roche, Amgen and Others (includes corresponding Graph/Chart)

Table 4. Leading Pharmaceutical Companies in the Pre-Filled Anti-Coagulant Syringes Market (2011): Percentage Breakdown of Revenues for Sanofi, GSK and Others (includes corresponding Graph/Chart)

Ready-to-Fill Segment Goes Strong

Table 5. Global Ready-to-Fill Syringe Consumption: 2007-2011 (In Billion Units) (includes corresponding Graph/Chart)

Table 6. Leading Pharmaceutical Companies by Pre-filled Syringe Consumption (2011): Percentage Breakdown of Value Consumption for Sanofi, GSK, Novartis, Pfizer, Roche and Others (includes corresponding Graph/Chart)

Table 7. World Sales of Drugs in Pre-filled Syringes by Therapeutic Class (2011): Percentage Breakdown of Revenues for Vaccines, Hematology, Multiple Sclerosis, Anti-inflammatory, Anticoagulants and Others (includes corresponding Graph/Chart)

2.PRODUCT OVERVIEW

Introduction
Historical Background
Mechanism
Safety Syringe
Pre-Filled Syringe
Oral Vaccines
Nasal Sprays, Suppositories and Eye and Nose Drops
Inhalers
Transdermal
Injected Fine Mist or Powder
Jet Injectors
Iontophoretic Transdermal
Patches
Implants
Microneedles
Material Used for Production
Designing of Needle-free Injection Systems
The Production Process
Manufacturing the Pieces
Assembling and Labeling
Packaging
Quality Control
Safe Medical Devices
Auto-Injectors and Pen Injector
Benefits for Human
Greater Patient Acceptance and Compliance
Enhanced Safety
Improved Effectiveness
Swift Injection Time
Advantages of Using Needle-Free Injectors in Animals
Disease Transmission Reduction
Immunology Improvement
Improvement in Beef Quality
Employee Safety
Needle-free Delivery of Liquids and Solids

3.PRODUCT INTRODUCTIONS

Revolutions Medical Launches New Improved Website
MedPro Safety Products Launches Pre-filled Safety Syringe
MedPro Safety Products Launches Passive Hypodermic Safety Syringe
Greiner Bio-One and MedPro Safety Products Launch PREMIUM Safety Needle System Tube-Touch
MIT Introduces MED-JET® Products in the Russian Market
Revolutions Medical Develops Pre-filled Auto Retractable Vacuum Safety Syringes
ALK-Abello Unveils Jext – A New Adrenaline Auto-Injector
Fred Meyer Stores Offers Bioject Medical Technologies’ Biojector® 2000
Revolutions Medical Introduces New Automatic Retractable Safety Syringe Designs
Revolutions Medical Unveils 3ml RevVac Safety Syringe
SCHOTT Pharmaceutical Packaging Develops InJentle™
PharmaJet Develops Needle-Free Jet Injection Technology
Smiths Medical Launches Medfusion® 4000 Syringe Infusion Pump
Teva Pharmaceutical Industries Rolls Out New Tjet™ Needle-Free Injector System
Occupational and Medical Innovations Rolls Out Auto-Retractable Safety Syringe
Pharmastandard to Launch Ypsomed’s Ypsopen in Russia

4.RECENT INDUSTRY ACTIVITY

Insvet and AcuShot™ Ink Distribution Agreement
Antares Pharma Receives US Patent for Vibex™ Technology
Paketeria Acquires INJEX Pharma
Unilife Commences Sale of Unifill Ready-to-fill Syringes to Multinational Pharmaceutical Company
Zogenix and DURECT Sign Development and License Agreement
Clinigen Pharma and Zogenix Sign Collaborative Agreement
Bioject Medical Technologies to Supply Intradermal Pen
Revolutions Medical to Manufacture 5 million RevVac 1ml Fixed Needle Safety Syringe Every Month
Revolutions Medical Receives Clearance from the DLA for the RevVac Safety Syringe
Revolutions Medical Files Provisional Patent Application for Vacuum Technology-based Pre-Filled Safety Syringes
Medical International Technology Gains Chinese SFDA Certification for MED-JET® Products
Revolutions Medical and CeifiT Ink Marketing and Distribution Agreement
Revolutions Medical and DS WorldMed Ink Marketing and Distribution Agreement
Revolutions Medical and Wuxi Yushou Medical Appliance Ink Definitive Manufacturing Agreement
INJEX Pharma and Al Shamali Group Ink an Exclusive Distributor Contract
INJEX Pharma Inks Exclusive Sales and Marketing Agreement with GenTech Laboratories for INJEX Needle-Free Syringes
Unilife Bags Supply Contract for Unitract Safety Syringes from Premier Purchasing Partners
US FDA Grants Two 510(k) Marketing Clearances for PharmaJet’s IM/SC Injection Technology
Zogenix Ends Co-Promotion Agreement with Astellas Pharma for the SUMAVEL DosePro
Kroger Include PharmaJet Needle-Free Injection Systems in Flu-Shot Campaign
Valeritas’ V-Go™ Disposable Insulin Delivery Medical Device Obtains CE Mark Approval
Revolutions Medical Receives Patent for Marketing RevVac Safety Syringe in the Chinese Market
Zogenix and Desitin Obtain Marketing Approval for SUMAVEL DosePro
Smiths Medical to Establish Subsidiary in India
Unilife Commences Unifill Pre-filled Syringe Production
PharmaJet Secures FDA Clearance for Intradermal Needle-Free Injection Device
Cadence Enters into Agreement for Acquiring Incline Therapeutics
PharmaJet Signs Collaboration Agreement with USAMRIID
Revolution Medical and Santa Monica Pharmaceutica Enter into Strategic Partnership
Standard Chem and Pharm Enters into Distribution Agreement with Unilife
Bioject Medical Technologies and MPI Research Enter into Alliance
Revolutions Medical and MIG Sign Manufacturing Agreement
Protectus Medical Devices Inks Agreement with Moll
Unilife Starts Selling Unitract® 1ml Syringes
Inviragen and PharmaJet Obtain NIAID Contract for Developing Needle-Free Dengue Vaccine
Safety Syringes Selects Polycarbonate Resin of Bayer MaterialScience
Incline Therapeutics and ALZA Enter into Agreement
Desitin Pharmaceuticals and Zogenix Obtain Marketing Authorization for SUMAVEL® DosePro™ from Danish Medicines Agency
Antares Pharma Announces Advancements in Vibex™ Auto-Injectors
TOLMAR Holding Acquires QLT USA
SquareOne Medical Completes Reverse Merger into E-18
West Pharmaceutical Services Takes Over Assets of Plastef Investissements
Revolutions Medical Obtains FDA Approval for Marketing Rev Vac Safety Syringe
Bioject Medical Technologies and Ferring Pharmaceuticals Extend Supply Agreement
Med-Pharmex and AcuShotTM Ink Exclusive Distribution Agreement
Revolutions Medical and Libra International Ink Distribution Agreement
Cardinal Health and OMI Ink Exclusive Distribution Agreement
Astellas Pharma and Zogenix Ink Agreement to Co-Promote Sumavel DosePro
Unilife and Sanofi Winthrop Industrie Ink Industrialization Agreement
Bioject Medical Technologies Receives FDA 510(k) Clearance for ZetajetTM
PharmaJet Collaborates with PATH
Lipoxen and Glide Pharma Ink Agreement
Ypsomed Holding and Gamma Medica Enter into Distribution Agreement
Zogenix Receives FDA Approval for SUMAVEL® DoseProTM

5.FOCUS ON SELECT KEY PLAYERS

First Principals, Inc. (US)
Cambridge Consultants Ltd. (UK)
Antares Pharma, Inc. (US)
Bard Biopsy Systems (US)
Baxter International, Inc. (US)
Baxter BioPharma Solutions (US)
Bector, Dickinson (US)
BD Medical
Bioject Medical Technologies, Inc. (US)
Covidien Plc (Ireland)
Crossject Ltd. (France)
D'Antonio Consultants International, Inc. (US)
Glide Pharmaceutical Technologies Ltd. (UK)
Incline Therapeutics, Inc. (US)
INJEX Pharma GmbH (Germany)
Medical International Technologies (Mit Canada), Inc. (Canada)
National Medical Products, Inc. (US)
PenJet Corporation
PowderJect Pharmaceuticals Plc (UK)
Retractable Technologies, Inc. (US)
Safety Syringes, Inc. (US)
Smiths Group (UK)
Smiths Medical (US)
Terumo Corporation (Japan)
Unilife Medical Solutions Ltd. (US)
Valeritas (US)
Ypsomed Holding AG (Germany)
Zogenix, Inc. (US)

6.GLOBAL MARKET PERSPECTIVE

Table 8. World Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 9. World Historic Review for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

Table 10. World 15-Year Perspective for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2011 and 2018 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. Market Analysis
Current and Future Analysis
The Torch Bearers
Leading Players Operating in the Largest Individual Market
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 11. US Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 12. US Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

2.CANADA

A. Market Analysis
Current and Future Analysis
Product Launch
Medical International Technologies (Mit Canada), Inc. – A Leading Canadian Player
B. Market Analytics

Table 13. Canadian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 14. Canadian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

3.JAPAN

A. Market Analysis
Current and Future Analysis
Terumo Corporation – A Leading Japanese Player
B. Market Analytics

Table 15. Japanese Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 16. Japanese Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4.EUROPE

A. Market Analysis
Current and Future Analysis
Region-Wide Laws on Safety Syringes on the Cards
B. Market Analytics

Table 17. European Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 18. European Historic Review for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

Table 19. European 15-Year Perspective for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2004, 2011 and 2018 (includes corresponding Graph/Chart)

4A.FRANCE

A. Market Analysis
Current and Future Analysis
Strategic Corporate Developments
Crossject Ltd. – A French Player
B. Market Analytics

Table 20. French Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 21. French Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4B.GERMANY

A. Market Analysis
Current and Future Analysis
Product Launch
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 22. German Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 23. German Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4C.ITALY

Market Analysis

Table 24. Italian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 25. Italian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4D.THE UNITED KINGDOM

A. Market Analysis
Current and Future Analysis
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 26. UK Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 27. UK Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4E.SPAIN

A. Market Analysis
Current and Future Analysis
Strategic Corporate Development
B. Market Analytics

Table 28. Spanish Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 29. Spanish Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4F.RUSSIA

A. Market Analysis
Current and Future Analysis
Product Launches
B. Market Analytics

Table 30. Russian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 31. Russian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4G.REST OF EUROPE

A. Market Analysis
Current and Future Analysis
Product Launch
Strategic Corporate Developments
Covidien Plc – An Irish Player
B. Market Analytics

Table 32. Rest of Europe Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 33. Rest of Europe Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

5.ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
Demand for Safety Syringes in Asia Yet to Take Off
Safety Syringe Market in India Sets Off
Product Launch
Strategic Corporate Developments
B. Market Analytics

Table 34. Asia-Pacific Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 35. Asia-Pacific Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

6.REST OF WORLD

A. Market Analysis
Current and Future Analysis
Strategic Corporate Developments
B. Market Analytics

Table 36. Rest of World Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)

Table 37. Rest of World Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 93 (including Divisions/Subsidiaries - 104)
The United States (46)
Canada (7)
Japan (2)
Europe (21)
- France (5)
- Germany (5)
- The United Kingdom (5)
- Rest of Europe (6)
Asia-Pacific (Excluding Japan) (27)
Middle-East (1)